|
시장보고서
상품코드
2051348
약물 남용 치료 시장 : 남용 형태별, 약물 유형별, 유통 채널별, 지역별Drug Abuse Treatment Market, By Abuse Type, By Drug Type, By Distribution Channel, By Region |
||||||
약물 남용 치료 시장은 2026년에 262억 달러로 추정되며, 2033년까지 457억 8,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 8.3%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 262억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 8.30% | 2033년 시장 규모 예측 : | 457억 8,000만 달러 |
세계 약물 남용 치료 시장은 최근 몇 년 동안 괄목할 만한 성장을 거듭하고 있습니다. 주로 불법 약물의 접근성 및 정신 건강 문제 증가로 인한 약물 남용 장애의 유병률 증가로 인해 효과적인 치료법의 필요성이 대두되고 있습니다. 또한, 중독 치료를 위한 다양한 약물 치료와 심리치료에 대한 인식이 높아지면서 더 많은 사람들이 전문적인 도움을 요청하고 있습니다. 치료 프로그램을 장려하는 다양한 정부의 이니셔티브와 더불어 약물 남용에 대한 건강보험 적용 범위가 확대되면서 시장 확대에 힘을 실어주고 있습니다. 그러나 약물중독에 대한 사회적 편견으로 인해 많은 환자들이 가능한 치료법을 적극적으로 받지 않으려는 상황이 지속되고 있습니다.
시장 역학
세계 약물 남용 치료 시장은 주로 세계 약물 남용 장애의 유병률 증가에 의해 주도되고 있습니다. 최근 추정에 따르면, 2023년에는 전 세계적으로 3,100만 명 이상이 약물 사용 장애를 앓고 있다고 합니다. 밀매 네트워크의 확대와 사회적 수용성 증가로 인한 마약의 접근 용이성이 소비율의 상승을 가져오고 있습니다. 또한, 우울증이나 불안 장애와 같은 정신 건강 문제 증가는 종종 개인을 약물 의존으로 이끌며, 그 결과 치료 제공업체에게 이익을 가져다줍니다. 코카인, 알코올, 오피오이드, 대마초 중독에 대한 다양한 약물 치료와 심리치료도 수요를 촉진하고 있습니다. 그러나 경제적 제약이 큰 장벽으로 작용하고 있으며, 많은 환자들에게 외래 재활 프로그램은 고가의 비용이 소요됩니다. 또한, 일부 지역에서는 사회적 지원의 부족도 회복의 성공을 방해하는 요인으로 작용하고 있습니다. 그럼에도 불구하고, 유리한 규제와 인식 개선 캠페인을 통한 정부의 지원은 지속적인 시장 성장을 위한 유망한 기회를 제공합니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 이 보고서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 연구는 다음과 같은 매개 변수를 기반으로 세계 약물 남용 치료 시장의 주요 기업을 프로파일링합니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 세계 약물 남용 치료 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 약물 남용 치료 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 쉽게 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 약물 남용 치료 시장 : 남용 유형별, 2021년-2033년
제5장 세계의 약물 남용 치료 시장 : 약제 유형별, 2021년-2033년
제6장 세계의 약물 남용 치료 시장 : 유통 채널별, 2021년-2033년
제7장 세계의 약물 남용 치료 시장 : 지역별, 2021년-2033년
제8장 경쟁 구도
제9장 섹션
LSH 26.06.18Drug Abuse Treatment Market is estimated to be valued at USD 26.20 Bn in 2026 and is expected to reach USD 45.78 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 26.20 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.30% | 2033 Value Projection: | USD 45.78 Bn |
Global drug abuse treatment market has been witnessing significant growth in the recent years. Rising prevalence of substance abuse disorders mainly due to easy availability of illicit drugs and growing mental health issues have necessitated effective treatment options. Moreover, increasing awareness about various pharmacological and psychological therapies for addiction treatment is driving more individuals to seek professional help. Various government initiatives promoting treatment programs along with growing health insurance coverage for substance abuse are also fueling the market expansion. However, social stigma associated with drug addiction continues to deter many patients from actively pursuing the available treatment options.
Market Dynamics
Global drug abuse treatment market is primarily driven by growing substance abuse disorder prevalence worldwide. According to recent estimates, over 31 Mn people globally suffer from substance use disorders in 2023. Easy accessibility of drugs due to flourishing trafficking networks and rising social acceptance has resulted in higher consumption rates. Moreover, increasing mental health problems such as depression and anxiety often lead individuals towards substance dependency, thereby benefitting treatment providers. Various pharmacological and psychological therapies available for cocaine, alcohol, opioid, and cannabis addiction are also boosting the demand. However, financial constraints constitute a major restraint with outpatient rehab programs being costly for many patients. Lack of social support also acts as an impediment for successful recovery in a few regions. Nonetheless, government support through favorable regulations and public awareness campaigns present lucrative opportunities for sustained market growth.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global drug abuse treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Cipla Limited, Glenmark Pharmaceuticals, Pfizer Inc., Mylan N.V., Odyssey Pharmaceuticals Inc., Lil' Drug Store Products Inc., Indivior Plc., Dr. Reddy's Laboratories, Teva Pharmaceutical Industries Ltd., British American Tobacco Plc., Alkermes, Sun Pharmaceuticals, BioCorRx, Inc., DXC Technology Company, and GenoLogics.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global drug abuse treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug abuse treatment market.
Market Segmentation
- Global Drug Abuse Treatment Market, By Abuse Type (Revenue, USD Bn, 2021 - 2033)
- Alcohol Dependence
- Tobacco/Nicotine Addiction
- Opioid Addiction
- Global Drug Abuse Treatment Market, By Drug Type (Revenue, USD Bn, 2021 - 2033)
- Disulfiram
- Acamprosate
- Naltrexone
- Methadone
- Buprenorphine
- Nicotine Addiction Treatment
- Nicotine Replacement Treatment
- Nicotine Patch
- Nicotine Gum
- Nicotine Lozenge
- Nicotine Spray
- Nicotine Inhaler
- Non-Nicotine Medication
- Bupropion
- Varenicline
- Others
- Global Drug Abuse Treatment Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Drug Abuse Treatment Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Cipla Limited
- Glenmark Pharmaceuticals
- Pfizer Inc.
- Mylan N.V.
- Odyssey Pharmaceuticals Inc.
- Lil' Drug Store Products Inc.
- Indivior Plc.
- Reddy's Laboratories
- Teva Pharmaceutical Industries Ltd.
- British American Tobacco Plc.
- Alkermes
- Sun Pharmaceuticals
- BioCorRx, Inc.
- DXC Technology Company
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Abuse Type
- Market Snippet, By Drug Type
- Market Snippet, By Distribution Channel
- Market Snippet ,By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Novel drug development
- Social stigma associated with drug abuse
- Strategic collaboration between market players
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Mergers, Acquisitions, and Collaborations
4. Global Drug Abuse Treatment Market, By Abuse Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Alcohol Dependence
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Tobacco/Nicotine Addiction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Opioid Addiction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Drug Abuse Treatment Market, By Drug Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Disulfiram
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Acamprosate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Naltrexone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Methadone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Buprenorphine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Nicotine Addiction Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Nicotine Replacement Treatment
- Nicotine Patch
- Nicotine Gum
- Nicotine Lozenge
- Nicotine Spray
- Nicotine Inhaler
- Non-Nicotine Medication
- Bupropion
- Varenicline
- Nicotine Replacement Treatment
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Drug Abuse Treatment Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Drug Abuse Treatment Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Company Profile
- Cipla Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Glenmark Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Odyssey Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lil' Drug Store Products Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Indivior Plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Reddy's Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- British American Tobacco Plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Alkermes
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sun Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BioCorRx, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- DXC Technology Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GenoLogics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cipla Limited
- Analyst Views
9. Section
- References
- Research Methodology
- About us
